Front‐line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real‐world setting: A multicenter retrospective study in China

BACKGROUND: The use of proteasome inhibitors (PIs), new immune modulators (IMiDs), and other new drugs, as well as high‐dose chemotherapy combined with autologous stem cell transplantation has considerably improved the survival of young patients with multiple myeloma (MM). However, the improvement i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Li, Liu, Ai‐Jun, Chu, Bin, Wang, Qian, Dong, Yu‐Jun, Lu, Min‐Qiu, Shi, Lei, Gao, Shan, Wang, Yu‐Tong, Wang, Li‐Fang, Chen, Wen‐Ming, Zhuang, Jun‐Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939119/
https://www.ncbi.nlm.nih.gov/pubmed/36271592
http://dx.doi.org/10.1002/cam4.5234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939119/
https://www.ncbi.nlm.nih.gov/pubmed/36271592
http://dx.doi.org/10.1002/cam4.5234

Ejemplares similares